Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer
It is crucial to understand molecular alterations in breast cancer and how they relate to clinicopathologic factors. We have previously shown that the glucocorticoid receptor (GCR) protein expression was reduced in invasive breast carcinoma compared to normal breast tissue. Glucocorticoids, signalin...
Main Authors: | Umaima Al-Alem, Garth H. Rauscher, Qais Al Alem, Andre Kajdacsy-Balla, Abeer M. Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/12/3151 |
Similar Items
-
SGK1 in Cancer: Biomarker and Drug Target
by: Jonas Cicenas, et al.
Published: (2022-05-01) -
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
by: Ilaria Guerriero, et al.
Published: (2020-11-01) -
Expression of Bcl-2 Family Member Bid in Normal and Malignant Tissues
by: Maryla Krajewska, et al.
Published: (2002-01-01) -
The functional duality of SGK1 in the regulation of hyperglycemia
by: Chunliang Yang, et al.
Published: (2020-08-01) -
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition
by: Cristina Talarico, et al.
Published: (2016-10-01)